LifeStance Health Group, Inc. (NASDAQ:LFST) Investigation

NEW YORK – February 8, 2024 – Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a preeminent national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. (“LifeStance” or “the Company”) (NASDAQ:LFST) for violations of the securities laws.

The focus of the investigation is to whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.. LifeStance was the subject of a report published by Hindenburg Research on February 1, 2024, titled: “LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.”

According to the report, “Overall, we think LifeStance is a classic example of what happens when private equity meets a ‘hot’ healthcare sector: Massive debt fueling a grinding, metric-focused corporate culture resulting in worse quality of care for patients, a worse environment for clinicians and long-term losses for the average investor.”

After the release of this report, shares of LifeStance fell by more than 8%.

Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas, and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.

If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735 or via e-mail at


Wolf Haldenstein Adler Freeman & Herz LLP

Gregory Stone, Director of Case and Financial Analysis

Email: or

Tel: (800) 575-0735 or (212) 545-4774